Hugh O'Dowd

Hugh O'Dowd currently works at ONK Therapeutics Ltd., as Independent Non-Executive Chairman from 2021.
Mr. O'Dowd also formerly worked at TherapeuticsMD, Inc., as President, Chief Executive Officer & Director from 2021 to 2022, BioNTech US, Inc., as President, Chief Executive Officer & Director from 2016 to 2020, Spexis Ltd., as Director, Puma Biotechnology, Inc., as Independent Director from 2019 to 2021, Novartis Oncology, Inc., as Chief Commercial Officer & Head-Global Strategy from 2011 to 2015, Novartis UK Ltd., as President & General Manager from 2015 to 2016, Novartis Ireland Ltd., as President & General Manager from 2015 to 2016, and Novartis International Pharmaceutical Ltd., as General Manager from 2015 to 2016.
Mr. O'Dowd received his undergraduate degree from Loyola University of Chicago and Masters Business Admin degree from Kellstadt Graduate School of Business.